Total Funding
37
11
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
501577
Biogazelle is a specialist in genomic testing solutions.
Acquired by 
CellCarta
Jan Hellemans: Site Manager, Genomics UnitPast Role: Biogazelle, Founder
CellCarta
About the Company
Biogazelle offers expert laboratory services in nucleic acid quantification (gene expression, mutation, and copy number analysis, antisense oligonucleotide screening) to support its customers in their development of diagnostics and therapeutics. Customized workflows for clinically relevant samples – from liquid biopsies to fixed tissues – are
available. In addition, Biogazelle’s advanced RNA biomarker development program offers an end-to-end solution from RNA biomarker panel discovery (including liquid biopsies) to the development of a PCR-based molecular diagnostic test. Biogazelle also serves as a specialty lab in the field of clinical trials and in routine diagnostic settings.
